Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net (loss) income $ (1,273) $ 40,805
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Realized loss from maturity of marketable securities 133
Loss (gain) on sale of assets, net of taxes 160 (42,389)
Change in valuation allowance, income tax (1,322)
Depreciation and amortization 287 525
Stock-based compensation expense 433 46
Changes in operating assets and liabilities:    
Accounts receivable 894 4,657
Inventory (1,186) 744
Prepaid and other assets 128 112
Accounts payable and accrued expenses (182) (1,653)
Accrued advertising and other allowances (113) (1,517)
Due to Mylan, Inc. and affiliates 319
Other current liabilities (641) (1,417)
Assets held for sale 22 (22)
Net cash used in operating activities (1,338) (1,112)
Cash flows from investing activities    
Net proceeds from the sale of assets 40,825
Purchase of marketable securities (12,034) (32,194)
Proceeds from maturities of marketable securities 14,280 8,518
Proceeds from sale of marketable securities 9,574
Capital expenditures (24) (202)
Net cash provided by investing activities 11,796 16,947
Cash flows from financing activities    
Payments to retire notes (1,500)
Payments to acquire treasury stock (11,802)
Payment of dividends (11,700)
Proceeds from exercise of warrants 69
Proceeds from exercise of stock options 338 854
Net cash used in financing activities (11,362) (12,379)
(Decrease) increase in cash and cash equivalents (904) 3,456
Cash and cash equivalents, at the beginning of the year 3,173 441
Cash and cash equivalents, at the end of the period 2,269 3,897
Supplemental disclosure of cash flow information:    
Cash paid for interest 54
Income taxes paid 1,350
Supplemental disclosure of non-cash investing activities:    
Escrow receivable 5,000
Net unrealized gain (loss), investments in marketable securities $ 54 $ (35)